Detailed Safety Profile of the Anti-Pd-1 Monoclonal Antibody Pembrolizumab in 78 Consecutive Patients (pts) with Advanced MelanomaC. Boutros,E. Routier, C. Hua,M. Texier,C. Mateus,C. Libenciuc,M. Reigneau,N. Benannoune,S. Roy,E. Lanoy,J. Le Pavec, F. L. Ladurie,F. Carbonnel,O. Lambotte,H. Izzedine,A. Berdelou,S. Champiat,J-C. Soria,A. Eggermont,C. RobertAnnals of Oncology（2016）引用 1|浏览39AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
